Achillion shareholders back Alexion takeover

Achillion Pharmaceuticals (ACHN +0.3%) stockholders voted overwhelmingly in favor of Alexion Pharmaceuticals’ (ALXN +0.6%) $6.30/share bid (~$930M).

The transaction includes contingent value rights (CVRs) that will pay out $1.00 per share triggered by the FDA nod for danicopan and $1.00 per share if a Phase 3 study of ACH-5228 is initiated.

https://seekingalpha.com/news/3527435-achillion-shareholders-back-alexion-takeover